KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Debt to Equity (2019 - 2025)

Evolent Health has reported Debt to Equity over the past 7 years, most recently at $2.34 for Q4 2025.

  • Quarterly results put Debt to Equity at $2.34 for Q4 2025, up 253.56% from a year ago — trailing twelve months through Dec 2025 was $2.34 (up 253.56% YoY), and the annual figure for FY2025 was $2.34, up 253.56%.
  • Debt to Equity for Q4 2025 was $2.34 at Evolent Health, up from $1.26 in the prior quarter.
  • Over the last five years, Debt to Equity for EVH hit a ceiling of $2.34 in Q4 2025 and a floor of $0.31 in Q4 2021.
  • Median Debt to Equity over the past 5 years was $0.56 (2023), compared with a mean of $0.67.
  • Biggest five-year swings in Debt to Equity: decreased 1.87% in 2024 and later surged 253.56% in 2025.
  • Evolent Health's Debt to Equity stood at $0.31 in 2021, then soared by 54.55% to $0.48 in 2022, then rose by 16.37% to $0.56 in 2023, then rose by 18.23% to $0.66 in 2024, then surged by 253.56% to $2.34 in 2025.
  • The last three reported values for Debt to Equity were $2.34 (Q4 2025), $1.26 (Q3 2025), and $0.92 (Q2 2025) per Business Quant data.